Your browser doesn't support javascript.
loading
The Role of Cytokines In bronchoalveolar Lavage Fluid in the Pathogenesis of the Neonatal Chronic Lung Disease
Article in Korean | WPRIM (Western Pacific) | ID: wpr-183918
Responsible library: WPRO
ABSTRACT

PURPOSE:

Chronic lung disease is a cause of significant morbidity and mortality in the neonatal respiratory distress syndrome. Although the exact mechanisms leading to the development of chronic lung disease are unknown, there is increasing evidence indicating that pulmonary inflammation contributes to the pathogenesis. The proinflammatory cytokines, interleukin(IL)-1beta, IL-8 may have a role to play in initiating the inflammatory response that is seen in chronic lung disease. In contrast, IL-10 is an antiinflammatory cytokine. The abnormal persistent inflammatory process in chronic lung disease may be due to dysregulation of these proinflammatory cytokines. So, to describe cytokine profiles of chronic lung disease in neonate, we analysed the IL-1beta, IL-8 and IL-10 levels in bronchoalveolar lavage fluid by ELISA technique.

METHODS:

We obtained bronchoalveolar lavage samples from 14 respiratory distress syndrome infants without chronic lung disease and 8 respiratory distress syndrome infants with chronic lungisease. The cytokine levels were assayed.

RESULTS:

The results were as follows 1) IL-1beta levels were higher in chronic lung disease group(205.16+/-360.21pg/rnl) than group without chronic lung disease(21.21+/-26.14pg/ml)(P0.05). 3) In contrast, IL-10 levels were lower in chronic lung disease group(78.29+/-138.69pg/ml) than group without chronic lung disease(111.29+/-155.27pg/ml)(P>0.05).

CONCLUSION:

These results suggest that the dysregulation of cytokines contributes to the pathogenesis of chronic lung disease. The difference in cytokine levels of bronchoalveolar lavage fluid can be used as a predictor for development of chronic lung disease.
Subject(s)

Full text: Available Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Target 3.2: Reduce avoidable death in newborns and children under 5 / Pneumonia / Other Respiratory Diseases / Infections / Neonatal Healthcare / Noncommunicable Diseases Database: WPRIM (Western Pacific) Main subject: Pneumonia / Respiratory Distress Syndrome, Newborn / Enzyme-Linked Immunosorbent Assay / Bronchoalveolar Lavage Fluid / Mortality / Cytokines / Interleukin-8 / Interleukin-10 / Bronchoalveolar Lavage / Lung Type of study: Etiology study / Prognostic study Limits: Humans / Infant / Infant, Newborn Language: Korean Journal: Journal of the Korean Society of Neonatology Year: 1998 Document type: Article
Full text: Available Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Target 3.2: Reduce avoidable death in newborns and children under 5 / Pneumonia / Other Respiratory Diseases / Infections / Neonatal Healthcare / Noncommunicable Diseases Database: WPRIM (Western Pacific) Main subject: Pneumonia / Respiratory Distress Syndrome, Newborn / Enzyme-Linked Immunosorbent Assay / Bronchoalveolar Lavage Fluid / Mortality / Cytokines / Interleukin-8 / Interleukin-10 / Bronchoalveolar Lavage / Lung Type of study: Etiology study / Prognostic study Limits: Humans / Infant / Infant, Newborn Language: Korean Journal: Journal of the Korean Society of Neonatology Year: 1998 Document type: Article
...